Once-Daily Intravenous Busulfan As Myeloablative, Reduced-Toxicity Conditioning Regimen: Results in Young and Adult Patients With Hematological Malignant and Nonmalignant Diseases. Hematol Meeting Rep 2009, 2 (6). https://doi.org/10.4081/hmr.v2i6.771.